THE USE OF CETIRIZINE AND LEVOCETIRIZINE IN PATIENTS WITH CHRONIC URTICARIA AND OTHER ALLERGIC DERMATOSES: ISSUES OF DOSAGE INCREASING AND LONG-TERM USE RESOLUTION OF THE ADVISORY BOARD

Abstract

The article reflects the main issues discussed at the Advisory board with the participation of leading dermatovenereologists, allergists and immunologists. The Advisory board has become a platform for discussing the accumulated clinical and organizational problems in the field of managing patients with chronic urticaria and other allergic dermatoses. The Board also discussed the possibility of long-term use of cetirizine and levocetirizine and the use of high doses of these drugs in clinical practice. The subject of discussion was the question of the algorithm for escalation and subsequent de-escalation of the dose of non-sedating H1 antihistamines. Based on the results of the discussion, an algorithm for escalation and de-escalation of doses of antihistamines was created, which can be recommended for use in clinical practice.